One honest note on evidence up front: almost none of the research peptides discussed on this site have an FDA-approved human indication, and the injection-technique literature that is robust comes from decades of clinical diabetes education subcutaneous insulin, site rotation, and lipohypertrophy prevention
The TRANSCEND-T2D-1 trial (NCT06354660) demonstrated HbA1c reductions of 1.7-2.0% and 36.6 lbs mean weight loss in type 2 diabetes participants over 40 weeks
However, these often involve research-grade products not intended for human use, no medical supervision or safety monitoring, questionable quality and purity, and legal and safety risks
Fast service Great service
CJC-1295 No DAC CJC-1295 No DAC CJC-1295 No DAC 5mg (Lyophilized Peptide) For Research Use Only CJC-1295 No DAC is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH) designed for research on stimulating natural growth hormone (GH) release in a pulsatile manner
